Digital Technologies: RFID, QR Codes, and IoT in Drug Packaging
Introduction: The Digital Transformation of Pharmaceutical Packaging
The pharmaceutical packaging industry is undergoing a profound digital transformation. What was once a passive container designed solely to protect and transport drugs is now evolving into an intelligent, connected platform that delivers value at every stage of the pharmaceutical lifecycle—from manufacturing and distribution to patient administration.
This transformation is driven by converging forces: regulatory mandates requiring end-to-end traceability, the urgent need to combat counterfeit drugs, the rise of temperature-sensitive biologics demanding real-time cold chain monitoring, and the growing expectation that packaging should actively support patient adherence and engagement. The market reflects this momentum—the global RFID in pharmaceuticals market is projected to expand from USD 5.97 billion in 2025 to USD 9.27 billion by 2031, while the broader smart medication packaging market is expected to grow at a CAGR of 9.9%.
At the heart of this revolution are three interconnected digital technologies: Radio Frequency Identification (RFID) , Quick Response (QR) Codes, and the Internet of Things (IoT) . Each plays a distinct yet complementary role in creating smarter, safer, and more patient-centric pharmaceutical packaging. For pharmaceutical packaging manufacturers like Vialab Pharmaceutical Packaging Co., Ltd. , understanding and integrating these technologies is essential to meeting the evolving needs of global healthcare partners.
This article explores the applications, benefits, and implementation considerations of RFID, QR codes, and IoT in drug packaging, examining how these digital technologies are reshaping the pharmaceutical supply chain and patient experience.
RFID: The Backbone of Supply Chain Visibility
Understanding RFID Technology
Radio Frequency Identification (RFID) is a wireless technology that uses electromagnetic fields to automatically identify and track tags attached to objects. In pharmaceutical packaging, RFID tags—tiny microchips connected to antennas—are embedded in labels, cartons, or closures. These tags store unique digital identifiers that can be read remotely without line-of-sight, enabling bulk scanning and automated data capture at speeds far beyond traditional barcodes.
RFID technology exists in several variants. UHF RFID (Ultra-High Frequency) is well-suited for automated authentication and high-speed inventory checks, supporting traceability throughout the supply chain. NFC (Near Field Communication) , a subset of RFID, enables short-range, encrypted communication via smartphones—ideal for direct patient engagement. RAIN RFID, which operates in the UHF spectrum, has emerged as a key standard for pharmaceutical applications, with 52.8 billion RAIN RFID tag chips shipped globally in 2024.
Achieving 100% Traceability
The most compelling evidence of RFID’s potential in pharmaceuticals comes from the Axia Institute at Michigan State University. In a landmark study aligned with GS1 standards and the U.S. FDA’s Drug Supply Chain Security Act (DSCSA) requirements, the Institute’s Pharma End-to-End RFID Pilot achieved 100% traceability across a simulated real-world supply chain.
Phase 1, completed in October 2023, demonstrated the technical feasibility of applying RAIN RFID to various drug formulations and pharmaceutical packaging types in a lab setting. Phase 2 went further, validating RAIN RFID’s scalability in mixed-product handling environments—including cardboard packaging and glass vials—while achieving real-time error detection and correction, with 20 exceptions identified and resolved instantly. The study also demonstrated integration with ERP systems, enabling automated reconciliation of shipments and inventory.
Phase 3, currently underway, will extend RAIN RFID integration to hospitals and enable item-level traceability up to the patient. As one industry observer noted, “RFID also enables streamlined cycle counts and helps ensure medications aren’t merely moving through the supply chain. It confirms they’re reaching hospitals, distributors, and ultimately the patient’s bedside, all while maintaining the same efficacy the pharmaceutical manufacturer intended”.
Combating Counterfeiting
Counterfeit drugs remain a persistent threat to patient safety. Fake versions of popular drugs like Ozempic® and oxytocin routinely make their way to consumers outside the manufacturer’s authorized supply chain, undermining consumer trust and posing significant safety risks.
RFID offers a powerful defense. UHF RFID tags embedded in cartons enable real-time tracking and provenance verification through encrypted tag data, ensuring product authenticity and integrity—critical for therapies such as biologics and injectables. As one expert explains, “This digital ID allows stakeholders—from manufacturers to pharmacists and patients—to verify a drug’s authenticity. This significantly reduces the risk of counterfeit drugs entering the system, as products can be authenticated upon delivery or administration”.
Digital First-Opening Indication
Innovations like Schreiner MediPharm’s Cap-Lock for Vials demonstrate how RFID can enhance primary packaging security. This solution combines analog first-opening indication with a label-integrated RFID chip that enables digital first-opening indication and tracking of individual vials at unit level. Previously opened containers can be automatically recognized, supporting medication management processes at hospitals and other healthcare settings. The integration of NFC functionality also enables easy digital smartphone-based authentication.
Inventory Management and Operational Efficiency
Beyond traceability and anti-counterfeiting, RFID delivers significant operational benefits. Manual inventory procedures are labor-intensive and susceptible to inaccuracies that may endanger patient safety; RFID automates these tasks, enabling immediate verification of crash carts and medication kits. Adopting RFID technology allows organizations to reach 99.9 percent inventory accuracy, significantly decreasing expiry waste and stockouts.
QR Codes: The Patient’s Digital Gateway
The Power of Simple Scanning
QR (Quick Response) codes are two-dimensional barcodes that can be scanned using standard smartphone cameras. Unlike RFID, which requires specialized readers, QR codes leverage the ubiquity of smartphones—making them an accessible, low-cost digital gateway for patients and healthcare providers alike.
In pharmaceutical packaging, QR codes serve multiple purposes: they provide instant access to digital instructions for use (IFUs), enable product authentication, support medication adherence tracking, and facilitate regulatory compliance.
Enhancing Patient Adherence
Medication non-adherence remains a major challenge in healthcare, particularly for patients managing chronic conditions or complex therapeutic regimens. Smart packaging technologies, such as QR codes and NFC, enhance patient interaction and adherence. As Sriman Banerjee of Takeda Pharmaceuticals notes, patient adherence is improving thanks to technologies that offer a more personalized approach.
One clinical study demonstrated that a QR code-based self-reporting system for pill intake showed high accuracy in estimating medication adherence and yielded good patient satisfaction. Patients simply scan an adhesive QR label with their smartphone at every pill intake, transmitting digital feedback.
Digital Patient Information and Accessibility
QR codes are also transforming how patients access drug information. In one innovative project, QR codes added to medicine packages enable patients to interactively read drug information via augmented reality (AR) technology. This approach is particularly valuable for patients with visual impairments, language barriers, or low digital literacy—NFC-enabled content can deliver spoken instructions, content in multiple languages, dynamic font resizing, and simplified navigation.
As one industry publication observed, “Smart secondary packaging is a practical tool for bridging these gaps and enabling equitable access to treatment”. Patients can also view instructional videos or contact healthcare professionals directly, increasing confidence and comfort with home treatments.
Regulatory Compliance and Serialization
QR codes play a crucial role in meeting regulatory serialization requirements. The DSCSA requires unit-level serialization of prescription drugs, with unique product identifiers on each saleable package. QR codes, encoded in accordance with international GS1 standards, contain information about the packaging such as production date, time, and plant.
China has also implemented rigorous traceability requirements. By 2026, all medical institutions must achieve full collection and upload of drug traceability codes. These codes—printed on drug packaging boxes as unique identity markers—enable full-process drug traceability.
IoT: Connecting Packaging to the Digital Ecosystem
The Internet of Things in Pharmaceutical Packaging
The Internet of Things (IoT) refers to the network of physical objects embedded with sensors, software, and connectivity that enables data collection and exchange. In pharmaceutical packaging, IoT transforms passive containers into active monitoring systems capable of tracking environmental conditions, location, and product status in real time.
IoT-enabled packaging integrates various technologies—RFID tags, NFC chips, temperature sensors, humidity sensors, and Bluetooth Low Energy (BLE) devices—into a connected ecosystem that provides visibility and actionable insights throughout the supply chain.
Cold Chain Monitoring: A Critical Application
One of the most impactful IoT applications in pharmaceutical packaging is cold chain monitoring for temperature-sensitive biologics and vaccines. These products require stringent environmental control, and even minor deviations in temperature can lead to spoilage.
By integrating BLE smart labels into product packaging, pharmaceutical companies can monitor each unit in real time, ensuring environmental conditions remain within safe thresholds. These labels cost $1-2 each and can be read by standard smartphones without specialized infrastructure. As Identiv CEO Kirsten Newquist explains, “This improves regulatory compliance, reduces waste, and builds trust with providers and patients”.
IoT sensors embedded in packaging and transport units continuously monitor critical conditions such as temperature and humidity, enabling proactive quality assurance. This capability is essential for maintaining Good Distribution Practices (GDP) compliance.
The Three-Part System
Modern cold chain logistics operates on a three-part system: sensors that detect problems in real time, packaging that provides reaction time, and connectivity fast enough to act on both. “Sensors tell you when temperature control fails. Packaging determines how long you have to fix it”. IoT-enabled packaging bridges these elements, creating an early warning system that protects high-value drug products.
Smart Blisters and Connected Devices
IoT extends beyond primary packaging to smart blisters and connected medication delivery devices. Smart blisters and bottles with embedded sensors can track dosage, send reminders via smartphone apps, and share data with healthcare providers. This technology is particularly valuable for supporting complex therapies, home-administered medications, and direct-to-patient delivery models.
The Synergy of Digital Technologies
A Unified Digital Identity
The true power of digital technologies in pharmaceutical packaging lies in their integration. Rather than operating in silos, RFID, QR codes, and IoT sensors work together to create a unified digital identity for each drug product.
As one industry expert notes, “The goal is to use a single digital ID for multiple purposes like monitoring temperature and product conditions throughout the supply chain, as well as enabling the patient to verify important information such as expiration date”. This integrated approach maximizes ROI by addressing multiple use cases—supply chain visibility, anti-counterfeiting, cold chain monitoring, regulatory compliance, and patient engagement—through a single digital infrastructure.
From Passive Container to Active Tool
“Smart packaging is no longer just a container; it’s a multifunctional platform that underpins product compliance and patient trust,” says Tiffany Overstreet, global innovation director at MM Pharma & Healthcare Packaging. “Smart and connected packaging are becoming integral to care and compliance, transforming packaging from a passive container into an active tool”.
This transformation is evident across the pharmaceutical lifecycle. RFID enables end-to-end supply chain visibility. QR codes provide patients with instant access to information and support. IoT sensors ensure cold chain integrity. Together, these technologies create a connected ecosystem that protects drug products, supports healthcare providers, and empowers patients.
Implementation Challenges and Considerations
Cost and Infrastructure
Despite the compelling benefits, implementing digital technologies in pharmaceutical packaging requires significant investment. The full-scale deployment of RFID infrastructure entails substantial expenses related to hardware acquisition, software integration, and ongoing system maintenance. These costs can discourage smaller distributors and manufacturers.
However, the ROI is realized across multiple critical areas. Smart packaging substantially reduces the risk of counterfeiting and spoilage—critical for high-value, temperature-sensitive medications—while enabling enhanced inventory management and operational efficiency.
Technical Hurdles
Technical challenges persist. Signal interference with metallic or liquid medical products frequently requires specialized and expensive engineering remedies. Integration with existing ERP systems and supply chain platforms demands careful planning and execution. Additionally, the lack of global regulatory harmonization creates complexity for manufacturers operating across multiple markets.
Data Privacy and Security
As packaging becomes more connected, data privacy and security become paramount. Digital IDs in drug packaging contain sensitive information about product location, condition, and chain of custody. Ensuring that this data is encrypted, secure, and accessible only to authorized stakeholders is essential for maintaining patient trust and regulatory compliance.
The Future of Digital Pharmaceutical Packaging
Regulatory Convergence
The regulatory landscape is evolving toward greater harmonization. The DSCSA in the United States, the EU’s Falsified Medicines Directive, and China’s traceability requirements all point in the same direction: end-to-end traceability through digital technologies. As these frameworks converge, the business case for digital pharmaceutical packaging will only strengthen.
AI and Predictive Analytics
The next frontier is the integration of artificial intelligence (AI) with IoT-enabled packaging. AI analytics can process the vast amounts of data generated by connected packaging to predict supply chain disruptions, optimize inventory management, and identify potential quality issues before they escalate.
Sustainability Through Digitalization
Digital technologies also support sustainability goals. QR codes can replace printed patient information leaflets, reducing paper waste. IoT sensors reduce spoilage by enabling proactive intervention in cold chain deviations. RFID improves inventory accuracy, reducing expiry waste. As one industry observer noted, “Sustainability is increasingly becoming a vital consideration for the pharma industry. Traditionally cautious, the sector is now embracing change at a quicker pace driven by the urgency of climate action.”
Patient-Centric Innovation
The future of digital pharmaceutical packaging is increasingly patient-centric. As care moves from hospitals to homes, packaging is becoming a vital link between pharmaceutical brands and the patients they serve. NFC-enabled cartons can guide patients with video demonstrations, medication reminders, or direct links to digital IFUs—all accessed with a tap of a smartphone.
Vialab’s Commitment to Digital Innovation
At Vialab Pharmaceutical Packaging Co., Ltd. , we recognize that digital technologies are reshaping the pharmaceutical packaging landscape. Our comprehensive portfolio—from injection pens and glass vials to sterile vials and tamper-evident closures—is designed to support the integration of digital solutions that enhance product safety, supply chain visibility, and patient engagement.
Our commitment to strict quality control, ISO and GMP compliance, ensures that any digital enhancements to our packaging solutions meet the highest standards of performance and reliability. Whether embedding RFID tags in labels, incorporating QR codes for patient information, or designing packaging that supports IoT sensor integration, Vialab has the expertise and capabilities to deliver.
As the digital transformation of pharmaceutical packaging accelerates, Vialab remains at the forefront—translating technological advances into practical, commercially viable solutions for global healthcare partners. Contact us today to learn how our pharmaceutical packaging solutions can support your digital traceability, patient engagement, and supply chain visibility goals.